LIPNAMAT, created in 1971 (Japan), from 440 sister brands and 4958 competing brands. The LIPNAMAT brand is owned by Takeda Pharmaceutical, a company listed in Francfort. Its International Securities Identification Number (ISIN) is JP3463000004. LIPNAMAT belongs to the Drug Manufacturers business sector.
Share price and profitability of the share Takeda Pharmaceutical (LIPNAMAT)
Buy Takeda Pharmaceutical share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
Takeda Pharmaceutical
(LIPNAMAT)
over 5 years*
EUR 18.10
Stock market history Takeda Pharmaceutical (LIPNAMAT)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
